Biomarin Pharmaceutical Inc (BMRN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BMRN.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
BMRN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BMRN as an investment opportunity.
- BMRN has a less percent of analysts bearish on the stock than nearly 100% of all US stocks.
- The number of analysts covering the stock of BMRN is higher than 97.9% of Pharmaceutical Products stocks.
- Biomarin Pharmaceutical Inc's variance in analysts' estimates is less than 6.03% of all US stocks.
- The upside potential (average analyst target price relative to current price) of BMRN is greater than 93.53% of stocks in the large market cap category.
- Biomarin Pharmaceutical Inc's average analyst price target is greater than 92.48% of Pharmaceutical Products stocks.
- Biomarin Pharmaceutical Inc's percentage of analysts bullish on the stock is higher than 22.92% of Pharmaceutical Products stocks.
- The change in bullishness amongst analysts of BMRN is less than nearly 100% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Biomarin Pharmaceutical Inc are BLUE, ALNY and NBIX.
Is BMRN a Buy, Hold or Sell? See the POWR Ratings now!